Asunto(s)
Trastornos de los Cromosomas/diagnóstico , Trastornos de los Cromosomas/genética , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Neoplasias/diagnóstico , Neoplasias/genética , Adulto , Deleción Cromosómica , Trastornos de los Cromosomas/terapia , Cromosomas Humanos Par 22/genética , Electroencefalografía , Femenino , Estudios de Asociación Genética/métodos , Pruebas Genéticas , Humanos , Cariotipo , Cariotipificación/métodos , Imagen por Resonancia Magnética/métodos , FenotipoRESUMEN
The design and synthesis of hydroxyethylamine isosteres as inhibitors of cathepsin D based on SAR data have been accomplished. A library of 96 of these hydroxyethylamine isosteres are described and many have proven to be very potent inhibitors of human cathepsin D activity as measured using a fluorometric assay technique, via peptide substrate Ac-Glu-Glu(Edans)-Lys-Pro-Ile-Cys-Phe-Phe-Arg-Leu-Gly-Lys(Methyl Red)-Glu-NH(2). Compounds showing strongest inhibition of cathepsin D activity were those that contain a hydroxyethyl-N'-2- or N'-(4-chlorophenyl)piperazine moiety (IC(50) values range from 0.55 to 8.5 nM), with N'-(2-pyrimidyl)piperizine (IC(50) values range from 0.5 to 21.6 nM), with N-N'- L-piperazinocolinamide (IC(50) values range from 0.001 - 0.25 nM), or N-N'-L-piperazinocolin-N-methylamide (IC(50) values range from 0.015 - 7.3 nM).